Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > A very bad sign

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jul 28, 2022 2:31pm

199 Views

Post# 34857756

RE:RE:RE:RE:A very bad sign

Big euro vacation errr, presentations to institutions. Canada and US don't seem to give a rats arrse about it so maybe the Europeans will. Can see the interest in the share price and volume this week.

Save company money and stop going on these road shows, they are pointless.

Spill should be getting the thyroid clinical trial going, not on a company funded vacation. No news on the horizon as far as the eye can see. Waiting over a year to scale the HIGHLY scaleable pouch. What a joke. A needle in a haystack is easier to find than patient 7.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages